NasdaqGS:GLUEBiotechs
Results: Monte Rosa Therapeutics, Inc. Confounded Analyst Expectations With A Surprise Profit
It's been a mediocre week for Monte Rosa Therapeutics, Inc. ( NASDAQ:GLUE ) shareholders, with the stock dropping 18...
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.